Effects on the human serum lipoprotein profile of β-glucan, soy protein and isoflavones, plant sterols and stanols, garlic and tocotrienols

Journal of Nutrition

Volumn 132, Issue 9, 2002, Pages 2494-2505

  Kerckhoffs, Daniëlle A J M ^a,b   Brouns, Fred ^b   Hornstra, Gerard ^b   Mensink, Ronald P ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Diet; Functional foods; Humans; Review; Serum lipoproteins

Indexed keywords

ALLICIN; ALPHA TOCOTRIENOL; BETA GLUCAN; BIOCHANIN A; CAMPESTANOL; CAMPESTEROL; DAIDZEIN; ESTRADIOL; FORMONONETIN; GENISTEIN; ISOFLAVONE DERIVATIVE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHYTOSTEROL; SITOSTANOL; SITOSTEROL; SOYBEAN PROTEIN; STANOL ESTER; STIGMASTEROL; TOCOPHEROL;

ADULT; BIOAVAILABILITY; DIETARY INTAKE; FEMALE; FOOD PROCESSING; GARLIC; HUMAN; HYPERCHOLESTEROLEMIA; HYPOCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; REVIEW; VISCOSITY;

ALLIUM SATIVUM; AVENA; GLYCINE MAX; HORDEUM VULGARE SUBSP. VULGARE;

EID: 0036714914     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/132.9.2494     Document Type: Review

References (124)

1. Lowering heart disease risk with cholesterol reduction: Evidence from observational studies and clinical trials
2. Association between baseline risk factors, cigarette smoking, and CHD mortality after 10.5 years
3. Lipids and risk of coronary heart disease: The Framingham study
4. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
5. Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects
6. Dietary fiber and coronary heart disease
7. Soluble fiber and serum lipids: A literature review
8. Effect of β-glucan from oats and yeast on serum lipids
9. Effect of oat gum on the physical properties of the gastrointestinal contents and on the uptake of D-galactose and cholesterol by rat small intestine in vitro
10. Effects of oat gum on blood cholesterol levels in healthy young men
11. Oat bran increases serum acetate of hypercholesterolemic men
12. Propionate inhibits hepatocyte lipid synthesis
13. Cholesterol-lowering effect of rolled oats
14. Oat products and lipid lowering: A meta-analysis
15. Oat β-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects
16. Food labeling: Health claims; oats and coronary heart disease: Proposed rule
17. The hypocholesterolemic effects of β-glucan in oatmeal and oat bran: A dose-controlled study
18. A controlled study on the effect of β-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: Relation to apolipoprotein E phenotype
19. Do beans and oat bran add to the effectiveness of a low-fat diet?
20. Effects of an oat bran concentrate on serum lipids in free-living men with mild to moderate hypercholesterolaemia
21. Effect of β-glucan level in oat fiber extracts on blood lipids in men and women
22. Consumption of oat milk for 5 weeks lowers serum cholesterol and LDL cholesterol in free-living men with moderate hypercholesterolemia
23. Modest doses of β-glucan do not reduce concentrations of potentially atherogenic lipoproteins
24. Barley and wheat foods: Influence on plasma cholesterol concentrations in hypercholesterolemic men
25. Postprandial lipid, glucose, insulin, and cholecystokinin responses in men fed badey pasta enriched with β-glucan
26. Plasma lipid changes after supplementation with β-glucan fiber from yeast
27. Lathosterol and other non-cholesterol sterols during treatment of hypercholesterolaemia with β-glucan-rich oat bran
28. Review of clinical studies on cholesterol-lowering response to soy protein
29. Meta-analysis of the effects of soy protein intake on serum lipids
30. Overview of proposed mechanisms for the hypocholesterolemic effect of soy
31. Soy protein and serum lipids
32. Soy protein and cardiovascular disease: The impact of bioactive components in soy
33. Soy protein, isoflavones and cardiovascular disease risk
34. Soy protein, thyroid regulation and cholesterol metabolism
35. Food labeling: Health claims; soy protein and coronary heart disease: Final rule
36. Dietary soy-derived isoflavone phytoestrogens: Could they have a role in coronary heart disease prevention?
37. Dietary phytoestrogens
38. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins
39. Biological effects of isoflavones in young women: Importance of the chemical composition of soya bean products
40. Soy protein and isoflavones: Their effects on blood lipids and bone density in postmenopausal women
41. Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver
42. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women
43. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins
44. Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men
45. Hypocholesterolemic effect of soymilk supplementation with usual diet in premenopausal normolipidemic Japanese women
46. Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women
47. The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women
48. A soy protein isolate rich in genistein and daidzein and its effects on plasma isoflavone concentrations, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men
49. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women
50. Effect of soy-based breakfast cereal on blood lipids and oxidized low-density lipoprotein
51. Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women
52. Soy isoflavone supplementation in postmenopausal women. Effects on plasma lipids, antioxidant enzyme activities and bone density
53. The effect of supplementation with isoflavones on plasma lipids and oxidisability of low density lipoprotein in premenopausal women
54. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women
55. The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolaemia
56. The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism
57. Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: A randomized controlled trial in humans
58. 7S globulin from soybean is metabolized in human cell cultures by a specific uptake and degradation system
59. Soy protein peptides regulate cholesterol homeostasis in HepG2 cells
60. Mini-review of dietary phytosterols: A review of metabolism, benefits and side effects
61. Comparison of intestinal absorption of cholesterol with different plant sterols in man
62. Effects of plant sterols and stanols on lipid metabolism and cardiovascular risk
63. Regulation of cholesterol metabolism by dietary plant sterols
64. Effects of plant stanol esters on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase mRNA expression on mononuclear blood cells of healthy men and women
65. Inhibition of cholesterol absorption in rats by plant sterols
66. Effects of 2 low-fat stanol ester-containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic subjects
67. Cholesterol reduction by different plant stanol mixtures and with variable fat intake
68. Vegetable oil based versus wood based stanol ester mixtures: Effects on serum lipids and hemostatic factors in non-hypercholesterolemic subjects
69. Soy sterol esters and β-sitostanol ester as inhibitors of cholesterol absorption in human small bowel
70. Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low-fat diet
71. Effects on serum lipids, lipoproteins and fat soluble antioxidant concentrations of consumption frequency of margarines and shortenings enriched with plant stanol esters
72. Cholesterol-lowering efficacy of a sitostanol-containing phytosterol mixture with a prudent diet in hyperlipidemic men
73. Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy
74. Spreads enriched with plant sterols, either esterified 4,4-dimethylsterols or free 4-desmethylsterols, and plasma total- and LDL-cholesterol concentrations
75. Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects
76. Plant sterol and stanol margarines and health
77. Sitostanol administered in lecithin micelles potently reduces cholesterol absorption in humans
78. Effects of plant stanol esters supplied in low-fat yogurt on serum lipids and lipoproteins, non-cholesterol sterols and fat soluble antioxidant concentrations
79. Food labeling: Health claims; plant sterol/stanol esters and coronary heart disease: Interim final rule
80. Therapeutic potential of plant sterols and stanols
81. Plant stanol ester margarine lowers serum total and low-density lipoprotein cholesterol concentrations of healthy children: The STRIP project
82. Stanol ester margarine alone and with simvastatin lowers serum cholesterol in families with familial hypercholesterolemia caused by the FH-North Karelia mutation
83. Therapeutic actions of garlic constituents
84. Intake of garlic and its bioactive components
85. Cholesterol-lowering effect of garlic extracts and organosulfur compounds: Human and animal studies
86. Effect of garlic on total serum cholesterol: A meta-analysis
87. Garlic as a lipid lowering agent - A meta-analysis
88. Garlic powder in the treatment of moderate hyperlipidaemia: A controlled trial and meta-analysis
89. Garlic for treating hypercholesterolemia: A meta-analysis of randomized clinical trials
90. Garlic shows promise for improving some cardiovascular risk factors
91. Garlic powder and plasma lipids and lipoproteins: A multicenter, randomized, placebo-controlled trial
92. Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism: A randomized controlled trial
93. Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein(a)
94. A randomized trial of the effects of garlic oil upon coronary heart disease risk factors in trained male runners
95. The effect of a garlic preparation on plasma lipid levels in moderately hypercholesterolemic adults
96. Gender may affect the action of garlic oil on plasma cholesterol and glucose levels of normal subjects
97. Hypocholesterolemic effect of an enteric-coated garlic supplement
98. Saponins in garlic as modifiers of the risk of cardiovascular disease
99. Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans
100. Isolation and identification of novel tocotrienols from rice bran with hypocholesterolemic, antioxidant, and antitumor properties
101. Lack of effect of tocopherol on plasma lipids and lipoproteins in man
102. The structure of an inhibitor of cholesterol biosynthesis isolated from barley
103. 2, and platelet factor 4 in pigs with inherited hyperlipidemias
104. Hypocholesterolemic activity of synthetic and natural tocotrienols
105. Effects of administration of α-tocopherol and tocotrienols on serum lipids and liver HMG CoA reductase activity
106. Tocotrienols regulate cholesterol production in mammalian cells by posttranscriptional suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase
107. Inhibitors of cholesterol biosynthesis: Hypocholesterolemic and antioxidant activities of benzopyran and tetrahydronaphthalene analogues of the tocotrienols
108. Effect of a palm-oil-vitamin E concentrate on the serum and lipoprotein lipids in humans
109. Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee)
110. Response of hypercholesterolemic subjects to administration of tocotrienols
111. Differential serum responses of tocopherols and tocotrienols during vitamin supplementation in hypercholesterolaemic individuals without change in coronary risk factors
112. Antioxidant effects of tocotrienols in patients with hyperlipidemia and carotid stenosis
113. A vitamin E concentrate rich in tocotrienols had no effect on serum lipids, lipoproteins, or platelet function in men with mildly elevated serum lipid concentrations
114. Studies of LDL oxidation following α, γ-, or δ-tocotrienyl acetate supplementation of hypercholesterolemic humans
115. Dietary α-tocopherol attenuates the impact of γ-tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in chickens
116. Effects of γ-tocotrienol on apoB synthesis, degradation, and secretion in HepG2 cells
117. γ-tocotrienol as a hypocholesterolemic and antioxidant agent in rats fed atherogenic diets
118. Nutritional and biochemical aspects of the hypolipidemic action of rice bran oil: A review
119. Novel tocotrienols of rice bran modulate cardiovascular disease risk parameters of hypercholesterolemic humans
120. The effect of the aged garlic extract, Kyolic, on the development of experimental atherosclerosis